Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Dummy pez

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Jun 19, 2022 9:55am

93 Views

Post# 34767422

RE:Dummy pez

Hahaha I guess your last 3 posts were absolutely not related to me and added so much value to the board.

get back on the meds dumpster, youre projecting again lmao!

Duster340 wrote: got fooled again hahaha, all he does is write up attack posts on me because i make him look like an idiot lol, people are anxious to read your next attack post, keep them coming i need a good laugh. maybe get your other personality dummydavgro to write one up as well, when pez has a bad day that is usually when his other personality davgro comes out. hahaha

<< Previous

Bullboard Posts

Next >>

Stockhouse DealRoom opens new Australian opportunities